New Hypulse Surface Analysis System to accelerate the understanding of material surfaces
A revolutionary advancement in X-ray photoelectron spectroscopy depth profiling
A revolutionary advancement in X-ray photoelectron spectroscopy depth profiling
New hybrid pipette combines manual control with fast electronic aliquoting
Additional capabilities for continuous Adeno-Associated Virus (AAV) and Lentivirus (LV) production for consistent quality, performance, and scalability
Roche's achievement marks an important step in broadening the clinical utility of mass spectrometry testing across routine labs
Innovation from Beckman Coulter Life Sciences makes high-parameter flow cytometry more accessible
New PhysioMimix in silico tools unlock deeper functional insights from existing assays, advancing translation of MPS data to predict human ADME behavior
This assay allows for the quantitative measurement of soluble sTREM2 in human cerebrospinal fluid and blood within just 35 minutes
Next-generation HEK293 transient expression system is driving breakthroughs in therapeutic development
AISight Dx now supports VENTANA DP 200 and DP 600 slide scanners for pathology laboratories
Accelerated platform delivers validated biomarkers with ready-to-use Optimer ligands in months rather than years
New range of StarBright™ Dyes developed specifically for spectral flow cytometry provide greater flexibility in immunology research
CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF
The MosaiQ instrument is a next-generation, continuous random-access immunoassay platform offering labs automation, simple workflows, fast, multiplexed results and actionable insights for complex-to-diagnose conditions
With its unique combination of low-cost and high accuracy, ppmSeq marks a real breakthrough in sequencing technology
Compact, high-sensitivity solution for accurate macromolecule analysis
Oncomine Dx Target Test approved to identify patients eligible for HERNEXEOS (zongertinib tablets), the first and only orally administered targeted treatment for HER2 (ERBB2)-mutant NSCLC
Enabling accurate and accessible ethyl alcohol testing across moderate complexity laboratories
Initiative to expand testing access to underserved U.S. communities
The launch marks the highlight of a 10-year journey
Researchers receive funding to explore how fluorescent materials can detect the presence of pesticides and herbicides in food production
AliveDx has received IVDR-CE Mark for its multiplexed MosaiQ AiPlex Vasculitis (VAS) assay, designed to speed diagnosis of ANCA-associated vasculitides and Anti-GBM (Goodpasture’s) disease
Direct, high-resolution imaging of cells on membrane inserts without removal or disruption
Enhance sample traceability, streamline inventory, and support compliance with a trusted, user-friendly LIMS solution